Wolf J - Search Results

1

Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation.

Manzke O, Tesch H, Borchmann P, Wolf J, Lackner K, Gossmann A, Diehl V, Bohlen H. Manzke O, et al. Among authors: wolf j. Int J Cancer. 2001 Feb 15;91(4):508-15. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1068>3.0.co;2-d. Int J Cancer. 2001. PMID: 11251974 Clinical Trial.

2

Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.

Wolf J, Draube A, Bohlen H, Jox A, Mücke S, Pawlita M, Möller P, Diehl V. Wolf J, et al. Int J Cancer. 1995 Feb 8;60(4):527-33. doi: 10.1002/ijc.2910600417. Int J Cancer. 1995. PMID: 7829268

3

Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.

Bohlen H, Manzke O, Titzer S, Lorenzen J, Kube D, Engert A, Abken H, Wolf J, Diehl V, Tesch H. Bohlen H, et al. Among authors: wolf j. Cancer Res. 1997 May 1;57(9):1704-9. Cancer Res. 1997. PMID: 9135012

4

Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors.

Mücke S, Draube A, Polack A, Pawlita M, Massoudi N, Staratschek-Jox A, Bohlen H, Bornkamm G, Diehl V, Wolf J. Mücke S, et al. Among authors: wolf j. Int J Cancer. 2000 May 1;86(3):301-6. doi: 10.1002/(sici)1097-0215(20000501)86:3<301::aid-ijc1>3.0.co;2-2. Int J Cancer. 2000. PMID: 10760815

5

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.

Weihrauch MR, Manzke O, Beyer M, Haverkamp H, Diehl V, Bohlen H, Wolf J, Schultze JL. Weihrauch MR, et al. Among authors: wolf j. Cancer Res. 2005 Jul 1;65(13):5516-9. doi: 10.1158/0008-5472.CAN-05-0100. Cancer Res. 2005. PMID: 15994922

6

Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.

Jox A, Taquia E, Vockerodt M, Draube A, Pawlita M, Möller P, Bullerdiek J, Diehl V, Wolf J. Jox A, et al. Among authors: wolf j. Cancer Res. 1998 Nov 1;58(21):4930-9. Cancer Res. 1998. PMID: 9810002

7

Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives.

Wolf J, Tesch H, Parsa-Parsi R, Engert A, Diehl V. Wolf J, et al. Ann Oncol. 1998;9 Suppl 5:S79-82. doi: 10.1093/annonc/9.suppl_5.s79. Ann Oncol. 1998. PMID: 9926242 Review.

8

Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.

Holliger P, Manzke O, Span M, Hawkins R, Fleischmann B, Qinghua L, Wolf J, Diehl V, Cochet O, Winter G, Bohlen H. Holliger P, et al. Among authors: wolf j. Cancer Res. 1999 Jun 15;59(12):2909-16. Cancer Res. 1999. PMID: 10383154

9

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.

Titzer S, Christensen O, Manzke O, Tesch H, Wolf J, Emmerich B, Carsten C, Diehl V, Bohlen H. Titzer S, et al. Among authors: wolf j. Br J Haematol. 2000 Mar;108(4):805-16. doi: 10.1046/j.1365-2141.2000.01958.x. Br J Haematol. 2000. PMID: 10792287 Free article.

10

Biology and therapy of Hodgkin's disease.

Wolf J, Diehl V. Wolf J, et al. Eur J Cancer. 1995;31A(5):830-1. doi: 10.1016/0959-8049(95)00107-t. Eur J Cancer. 1995. PMID: 7640071 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,534 results

Search Page

Filters